Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
BackgroundIn Parkinson's disease (PD), non-motor symptoms especially anxiety represent a significant and underappreciated burden. Despite the lack of particular validation in this demographic, the Hamilton Anxiety Rating Scale (HAM-A) is widely used in clinical and research contexts.MethodsA cross-sectional study of 200 Parkinson's disease patients (mean age 62.77 ± 8.32 years; 118 men and 82 females) was conducted. The Hoehn & Yahr (H&Y) scale was used to grade motor severity, whereas the HAM-A was used to measure anxiety.ResultsOf the patients, 52.5% of people (n = 105; mean score 13.85 ± 6.09) had anxiety (HAM-A ≥ 14). Age (r = 0.032; p = 0.657), disease duration (r = 0.115; p = 0.105), H&Y stage (r = -0.073; p = 0.305), and sex (p = 0.856) did not significantly correlate with the HAM-A score.ConclusionAlthough the HAM-A shows a high incidence of anxiety in Parkinson's disease (PD), its consistent lack of connection with clinical illness markers raises serious concerns about construct validity, which are probably caused by somatic item overlap. It is best to use disease-specific tools like the GAD-7 or Parkinson Anxiety Scale (PAS).
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.